Veeva Vault CRM Secures Fourteenth Top 20 Biopharma Client
A new agreement with a top 20 biopharmaceutical company has solidified Veeva Systems’ foothold in the pharmaceutical software market. The company’s Vault CRM platform, now serving 190 live customers, is increasingly viewed by major industry players as the primary infrastructure for integrating artificial intelligence into field operations.
This latest contract joins a growing roster of industry giants, including Amgen, Biogen, Eli Lilly and Company, and Regeneron, that have transitioned to the platform. By deploying agentic capabilities—such as the Agentic Call Report—the system automates the generation of commercial evidence, allowing teams to identify treatment barriers and refine engagement strategies with healthcare professionals.
"We are establishing a fundamentally new way of working that helps bring medicines to patients faster and more efficiently," said Arno Sosna, president of Veeva’s CRM Suite. The platform functions as the central hub for the Veeva Vault CRM Suite, aligning sales, marketing, and medical departments to ensure compliant and customer-centric interaction across all communication channels.
Comments (0)
No comments yet. Be the first!